LINC01392: A Potential Drug Target and Biomarker (G104355291)

Target Name: LINC01392

NCBI ID: G104355291

LINC01392

Other Name(s): Long intergenic non-protein coding RNA 1392 | long intergenic non-protein coding RNA 1392

LINC01392: A Potential Drug Target and Biomarker

LINC01392 is a long intergenic non-protein coding RNA (lncRNA) molecule that has been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that is expressed in a variety of tissues and cells, including brain, heart, and testes. LINC01392 has been shown to play a role in the regulation of cellular processes, including cell adhesion, migration, and survival.

Drug Target Potential

LINC01392 has been identified as a potential drug target due to its unique structure and the processes it is involved in. The non-coding RNA molecule is known for its ability to interact with several protein molecules, including the protein known as FAK. FAK is a protein that is known to play a role in cell adhesion, migration, and survival, and is a potential drug target for several diseases, including cancer.

Scientists have shown that LINC01392 can interact with FAK and regulate its activity. This interaction between LINC01392 and FAK suggests that LINC01392 may be a useful drug target for the treatment of diseases that are characterized by the over-expression of FAK.

Biomarker Potential

In addition to its potential as a drug target, LINC01392 has also been identified as a potential biomarker for several diseases. The non-coding RNA molecule has been shown to be involved in the regulation of cell adhesion, which is a critical process in the development and progression of many diseases.

Scientists have shown that LINC01392 is expressed in a variety of tissues and cells, including brain, heart, and testes, and that it is involved in the regulation of cellular processes that are important for disease development. This suggests that LINC01392 may be a useful biomarker for the diagnosis and treatment of diseases that are characterized by the over-expression of FAK.

Conclusion

LINC01392 is a long intergenic non-protein coding RNA molecule that has been identified as a potential drug target and biomarker. Its interaction with the protein FAK and its expression in a variety of tissues suggest that it may be a useful target for the treatment of diseases characterized by the over-expression of FAK. Further research is needed to confirm these findings and to develop a better understanding of the role of LINC01392 in disease.

Protein Name: Long Intergenic Non-protein Coding RNA 1392

The "LINC01392 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01392 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets